FDA renewal to support Critical Path Institute consortia advancing drug development
The FDA is seeking an application to renew a cooperative agreement with the Critical Path Institute to maintain and manage existing consortia. Funding will back collaborative projects in research, education, and outreach to accelerate drug development, manufacturing, and translational therapeutics, improving safety, efficacy, quality, and performance. Awards are subject to available FDA funds.…
The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative. This is in support of Load more
Funding Source
Awards & funding
Eligibility
Critical Path Institute
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers